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 Comparisons between three different techniques by which the boost dose was delivered to the tumor bed were 
carried out , aiming to present the best technique of treatment for right breast cancer patients.  
In this study, ten right sided breast cancer computed tomography (CT) scans were selected for ten early right breast 
cancer patients. We made three different treatment plans for each patient CT using three different irradiation techniques to 
deliver a prescribed boost dose of 10 Gy in 5 fractions to the boost PTV. In the first technique, two tangential photon 
beams were used, in the second technique we, two oblique photon beams were used and in the third technique, a single 
electron beam was used. The comparative analyses between the three techniques were performed by comparing the 
boost PTV- dose volume histograms (DVHs), the ipsilateral breast (right breast) DVHs, the ipsilateral lung (right lung) 
DVHs and the heart DVHs of the three techniques for each patient. Furthermore the dose that covering 100% , 95% of the 
volume (D100% , D95%) and the volume covered by 95% of the dose (V95%) of  the boost PTV of all techniques, were 
calculated for each patient to investigate the dose coverage of the target. 
Results showed that there were variations of the dose received by tumor bed, right breast and OARs depending on 
the technique used and the target location and size. A decrease of D100% than 90% of the prescribed dose was observed 
with the 3
rd
 technique for patients 8, 9 and 10, and was observed with the 2
nd
 technique for patient 5. A reduction of right 
breast dose was observed when the 3
rd
 technique was use in comparison with the 1
st
 and the 2
nd
 techniques for patients 
1, 2, 3, 4, 6 and 8.  Also reduction of right breast was observed when the 2
nd
 technique used in comparison with 1
st
 
technique. An increase of lung dose was observed with the 3
rd
 technique for patients 1, 2, 5 and 6, also was observed with 
2
nd
 technique in patient 3, 5 and 7. A decrease of lung dose was observed with the 1
st
 technique for patients 2, 4, 5, 6, 7, 8 
and 9 
An individualized treatment, several plans using different irradiation techniques should be developed for each patient 
individually to reach the best boost PTV dose coverage with minimal OARs’ dose.  
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1 INTRODUCTION  
Breast cancer is considered as the second diagnosed type of cancer “after non-melanoma skin cancer” in women with 
about 23% of total new cancer cases. Also it represents about 14% of cancer death among women 
[1]
. By the advances of 
the breast cancer treatment, the breast conserving therapy (BCT) became an accepted option for the treatment of most 
stage I or II invasive breast cancer in women instead of mastectomy. BCT is a technique of cancer treatment where the 
breast-conserving surgery (BCS) is used followed by adjuvant postoperative radiotherapy 
[2]
.the use of BCT improves the 
local control and the survival rate in early stage breast cancer patients 
[3]
, with decreasing of both cancer recurrence risk 
by 70% and death risk by 9%-12% 
[4]
.The two tangential fields is the most common and traditional technique used in the 
whole breast radiotherapy because of its technical simplicity, more over it has an advantage in sparing organs at risk 
(OARs). Over the last decade, this technique has evolved by the use of multi-leaf collimators (MLC) to deliver field-in-field 
(FIF) three-dimensional conformal therapy (3D-CRT) 
[5, 6]
 and intensity modulated radiation therapy (IMRT) variants 
[7, 8]
. 
An additional boost dose of 10 to 16 Gy delivered to the tumor bed has shown an additional gain in decreasing local 
recurrence in patients 
[9]
. The delivery of the boost dose to tumor bed has been performed sequentially following to the 
whole breast radiation therapy (RT). This Sequential boost reduces local recurrence
 [10]
 but increases the treatment 
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duration. Alternatively, the simultaneously integrated boost (SIB) technique has also been involved to BCT with the use of 
IMRT in breast cancer. With this method, the whole breast and the boost PTV are integrated in a single treatment plan
 [11]
. 
It was usual to deliver the boost dose to the tumor bed by using the electron beam. But today there are other boost 
techniques using the photon beam. Up till now, it is unclear which technique is recommended 
[9]
. So investigations are 
needed to describe the differences between them and to modify a new techniques to irradiate breast with minimal side 
effects on heart, lungs, skin and normal breast tissues. In this work, we compare between three different techniques by 
which the boost dose is delivered to the tumor bed in right breast, aiming to present the best technique of treatment for 
breast cancer patients. Since the right lunge is larger than the left lung and the irradiated area of right lung is larger so 
more precaution should be taken to decrease the side effect on the right lung. In the first technique we used two tangential 
photon beams, in the second technique we used two oblique photon beams and in the third technique we used a single 
electron beam. 
2 METHODS 
Ten right sided breast cancer computed tomography (CT) scans were selected for ten early breast cancer patients 
treated at Ayadi Al-Mostakbal Oncology Center, Alexandria, Egypt. Patients were treated with BCT after BCS. The CT 
scans were performed by CT system Somatom Emotion Duo (Siemens, Munich, Germany). Patients were scanned 
according to the standard protocol with 5 mm slice thickness, in the supine position and arms above head 
[3]
. Targets of 
different locations (upper, lower, medial, inner, outer, deep and superficial) and sizes were selected. 
The contouring of target and OARs was done by experienced radiation oncologist. The boost clinical target volume 
(boost CTV) that included the tumor bed was recognized by the scar, visualized seroma and surgical clips. The boost 
planning target volume (boost PTV) that included boost CTV and safety margin of 7 mm in all directions except for the 
skin, was delineated. Also the ipsilateral breast (right breast), ipsilateral lung (right lung), heart and whole ipsilateral breast 
volume less boost PTV were delineated.  
Three different treatment plans are made  for each patient CT using three different irradiation techniques to deliver a 
prescribed boost dose of 10 Gy in 5 fractions to the boost PTV, and decrease the dose delivered to ipsilateral breast, 
contralateral breast and OARs. The planning  aim was that the volume receiving 95% of the prescribed dose (V95%) of the 
boost PTV to be greater than 95% of the total boost PTV volume, and the volume that receiving 5 Gy of OARs except 
ipsilateral breast shouldn’t exceed 5% of the total organ volume. All plans were performed by a 3D planning system CMS 
Xio v4.5 (Elekta AB, Stockholm, Sweden) employing the superposition algorithm.  
All these plans were created for Siemens Artiste
®
 Treatment System Linear Accelerator (Linac) machine with a dual 
energy X-rays of 6 and 10 MV and multi-electron beam energies of 10, 15, 16 and 21 MeV. The beams produced have 
high dose rates (up to 600 cGy per minute), small penumbras (an 80% to 20% penumbra of 6 mm for 6 MV beams), and 
minimal field edge divergence at 100 cm source-to-surface distance (SSD). The machine gantry, collimator and table can 
rotate about isocenter point at 100 cm SSD. Gantry and collimator have rotation range of 360º. The machine provides 
stationary and moving radiation (arc or rotation) clockwise or counter clockwise for X-ray or electron beam. The machine 
head is provided with conventional collimators in X-direction and two backup diaphragms in Y-direction. Multileaf 
collimator (MLC) has two opposing sets, having 160-leaf multileaf collimator (MLC) with leaf width of 5mm and leaf-
positioning accuracy of 0.5 mm. The machine provides field sizes ranging from 1x1 to 40x40 cm
2
 at 100 cm SSD within 
accuracy ±1 mm for fields less than 20x20 cm
2
 and 1% for greater fields.  
In the first technique, two tangential photon beams were used to deliver the boost dose to the boost PTV and reduce 
unnecessary dose to OARs. The isocenter located approximately in the center of boost PTV. In the second technique, two 
oblique photon beams with individual selected gantry angle were used to deliver boost dose to the boost PTV and reduce 
unnecessary dose to OARs. The isocenter located approximately in the center of boost PTV. In the third technique, a 
single direct electron beam with SSD =100 cm was used to deliver the boost dose to the boost PTV and reduce 
unnecessary dose to OARs.For all techniques, the beam energy was chosen for each case individually depending on the 
target location and volume aimed to cover the boost PTV with 95% of the prescribed dose. 
The isodose distributions and dose volume histograms (DVHs) of the three techniques for the boost PTVs and OARs, 
were obtained by using 3D planning system CMS Xio v4.5 (Elekta AB, Stockholm, Sweden) for each patient. 
The comparative analyses between the three techniques were performed by comparing the boost PTV-DVHs, the 
ipsilateral breast (right breast) DVHs, the ipsilateral lung (right lung) DVHs and the heart DVHs of the three techniques for 
each patient. Furthermore the dose that covering 100% , 95% of the volume (D100% , D95%) and V95% of  the boost PTV of 
all techniques, were calculated for each patient to investigate the dose coverage of the target. Also the volume receiving 5 
Gy of OARs of all techniques were calculated for each patient. 
3 RESULTS AND DISCUTIONS 
Ten patients of right sided breast tumor with different sizes and position, as shown in table (1), were selected and 
assigned from patient 1 to patient 10. The dosemetric data of target and OARs for all patients are shown in tables (2), (3), 
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Table 1. The target position and dimension for right sided tumor. 




















11 Outer – Upper 14.51 5.0x3.0 1.5 4.8 1.5 10.0 
12 Central – Lower 24.41 4.0 3.0 1.2 4.1 1.8 9.3 
13 Outer – Lower 12.95 3.5x2.5 1.4 3.0 1.5 9.5 
14 Central - medial 30.71 4.0x6.5 1.5 3.0 3.5 Far  
15 Central - medial 47.93 4.6x4.5 1.6 4.7 0.2 7.2 
16 Central - Medial 12.45 1.8x3.4 1.0 3.0 0.8 6.7 
17 Outer – Medial 4.61 1.2x2.2 4.0 6.1 1.0 9.5 
18 Outer – Upper 39.83 4.3x6.9 3.2 5.4 1.6 6.6 
19 Outer – Upper 11.63 2.4x2.8 4.2 6.2 1.2 8.5 
20 Central - Lower 34.11 3.9x3.3 4.4 9.5 2.5 10.5 
 
Table 2. The global maximum doses, for right sided tumor patients. 
Patient   Patient ID Target volume 1
st
  technique (cGy) 2
nd
  technique(cGy)  3
rd
  technique(cGy) 
11 226815 14.51 1090 1026 1046 
12 246315 24.41 1049 1055 1040 
13 173915 12.95 1064 1024 1046 
14 446915 30.71 1059 1059 1130 
15 o99515 47.93 1108 1023 1082 
16 406915 12.45 1074 1029 1102 
17 o46416 4.61 1084 1022 1106 
18 240315 39.83 1090 1045 1379 
19 452515 11.63 1053 1072 1449 
20 121215 34.11 1081 1027 1420 
 




First technique (cGy) Second technique (cGy) Third technique (cGy) 
Mini. Mean  Max. Mini  Mean  Max. Mini.   Mean  Max. 
11 14.51 949 984 1013 948 986 1018 911 979 1046 
12 24.41 954 1002 1046 948 1007 1055 941 996 1040 
13 12.95 962 999 1034 953 997 1021 958 1000 1046 
14 30.71 850 998 1040 680 998 1049 850 992 1130 
15 47.93 918 1055 1100 746 1000 1023 948 1027 1078 
16 12.45 894 983 1042 841 979 1020 890 996 1102 
17 4.61 960 992 1007 965 995 1045 911 990 1050 
18 39.83 909 1004 1058 791 1005 1043 815 1014 1122 
19 11.63 949 999 1032 975 1019 1072 870 1156 1314 
20 34.11 962 998 1027 979 999 1027 292 964 1331 
 
Table 4. The doses covering 2%, 50%, 95%, 98% and 100% of PTV. 
Patient   First technique (cGy) Second technique (cGy) Third technique (cGy ) 
D2% D50% D95% D98% D100% D2% D50% D95% D98% D100% D2% D50% D95% D98% D100% 
11 1011 988 988 959 950 1017 992 963 957 950 1030 989 950 935 918 
12 1043 1006 971 966 941 1048 1013 969 960 931 1030 1003 968 959 919 
13 1031 1030 978 972 951 1019 1004 974 967 951 1030 996 977 970 951 
14 1032 1004 975 967 931 1041 1001 974 949 908 1050 999 959 942 932 
15 1094 1064 1007 988 931 1022 1008 980 961 832 1067 1038 991 978 941 
16 1039 985 947 939 901 1017 986 941 928 901 1060 1001 950 931 901 
17 1006 998 980 975 961 1017 1000 978 975 961 1045 1000 950 940 933 
18 1052 1006 980 975 951 1040 1011 979 968 901 1126 1026 930 912 829 
19 1028 1005 975 969 951 1052 1024 995 987 971 1282 1178 1009 956 876 
20 1023 1004 981 976 941 1013 1003 992 985 972 1282 1010 520 448 324 
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Table 6. The homogeneity indexes. 
 
     Table 5. The percentages of PTV volume covered  
                 with 95% and 100% of the prescribed dose. 
Patient   1
st
 technique (%) 2
nd
  technique(%) 3
rd
 technique(%) 
V95% V100% V95% V100% V95% V100% 
11 100 22 100 31 95 24 
12 99.9 61 99.8 66 99.5 56 
13 99.9 57 99.9 58 99.9 38 
14 99.8 62 98 53 98 49 
15 99.9 99 98.9 69 99.9 90 
16 91 31 91 25 95 51 
17 100 39 100 50 95 50 
18 100 61 99.5 73 91 70 
19 100 60 100 90 98.5 95.5 
20 99.9 62 100 67 59 51 
 
Table 7. The mean and the maximum doses of the left breast. 
Patient  First technique (cGy) Second technique (cGy) Third technique (cGy) 
Mean Max. Mean  Max. Mean  Max. 
11 419 1090 307 1025 221 1028 
12 452 1049 342 1040 229 1017 
13 417 1064 337 1024 194 1030 
14 482 1059 382 1059 278 1076 
15 557 1108 454 1021 482 1081 
16 395 1074 297 1029 212 1082 
17 243 1084 183 1016 178 1106 
18 495 1090 408 1045 343 1379 
19 387 1053 290 1052 424 1449 
20 286 1081 246 1005 214 1420 
 
Table 8. The mean and the maximum doses of the left lung. 
Patient  First technique (%) Second technique (%) Third technique (%) 
Mean Max. Mean  Max. Mean  Max. 
11 48 1014 49 794 160 945 
12 37 897 55 827 161 931 
13 25 820 39 844 31 952 
14 21 820 24 702 72 809 
15 42 950 99 943 301 1082 
16 44 971 58 891 169 983 
17 42 988 61 621 21 425 
18 28 946 65 916 77 711 
19 42 935 78 915 56 840 
20 20 710 17 308 7 121 
 
Table 9. The mean and the maximum doses of the heart. 
Patient  First technique (%) Second technique (%) Third technique (%) 
Mean Max. Mean  Max. Mean  Max. 
11 6.5 15 9 32 17.5 135 
12 6.6 18 5.9 11 22.6 210 
13 0 0 6 14 10.2 16.7 
14 0 0 6.9 14.9 24.4 85 
15 6.8 15 12.8 189 71.5 518 
16 8.3 50 8.1 100 73 550 
17 8 114 8 255 8 49 
18 7.8 24 43 378 10 128 
19 9 79 80 392 21 89 
20 6.9 14.9 5.8 15 3.1 45 
 
 









11 5.2 6.0 9.5 
12 7.7 8.8 7.1 
13 5.9 5.2 6.0 
14 6.5 9.2 10.8 
15 10.6 6.1 8.9 
16 10.0 8.9 12.9 
17 3.1 4.2 10.5 
18 7.7 7.2 21.4 
19 5.9 6.5 32.6 
20 4.7 2.8 83.4 
I S S N  2 3 4 7 - 3 4 8 7                                                   
 V o l u m e  1 3  N u m b e r  1  
 J o u r n a l  o f  A d v a n c e s  i n  P h y s i c s  
 
4609 | P a g e                                        
F e b r u a r y  2 0 1 7                                                       w w w . c i r w o r l d . c o m  
3.1 Patient 1  
the isodose distributions using the three techniques are shown in “figure 1”. The DVHs of boost PTV, ipsilateral 
breast, right lung and heart using the three techniques are shown in “figure 2”. 
From the boost PTV-DVHs of all treatment plans shown in “figure (2-a)”, we see similar boost PTV dose coverage.  
D95% was greater than 950 cGy, D100% was greater than 900 cGy and “V95%” was greater than 95% of the total volume of 
the target, for all techniques.  
From the right breast DVHs shown in figure (2-b), it was clear that the 3
rd
 technique presented the lowest breast dose. 
The volumes received doses (up to 900 cGy) were decreased by about 21% when the 3
rd
 technique used in comparison 
with the 1
st
 technique. The 3
rd
 technique was better than the 2
nd
 technique because it reduced the volumes received doses 
(up to 400 cGy) by 23%. In the region of doses greater than (400 cGy) the DVHs of the 2
nd
 and the 3
rd
 techniques were 
almost similar. The volumes received doses greater than (400 cGy) were decreased by about 17% when the 2
nd
 technique 
used in comparison with the 1
st
 technique. The mean right breast dose was 221 cGy with the 3
rd
 technique while it was 
307 cGy for the 2
nd
 technique and 419 cGy for the 1
st
 technique. 
Figure (2-c) shows the right lung DVHs for all techniques. It was clear that the volumes received dose of 500 cGy 




 techniques, while it was 7.6% for the 3
rd
 technique. Also 
increasing of “Dmean = 160 cGy” was observed with the 3
rd






The analysis of heart DVHs for all techniques are shown in figure (2-d), there weren’t any significant differences 















3.2 Patient 2  
the isodose distributions using the three techniques are shown in “figure 3”.  It’s clear that the boost PTV coverage for 
each technique was accepted. The DVHs of boost PTV, ipsilateral breast, right lung and heart using the three techniques 
are shown in “figure 4”. 
From the boost PTV-DVHs for all techniques, shown in figure (4-a), we see similar boost PTV dose coverage. D95% 
was greater than 950 cGy, D100% was greater than 900 cGy and V95% was greater than 95% for all techniques.  
From the right breast DVHs shown in figure (4-b), it was clear that the 3
rd
 technique presented the lowest breast dose. 
The volumes received doses (up to 900 cGy) were decreased by about 24.15% when the 3
rd
 technique was used in 
comparison with the 1
st
 technique. The 3
rd
 technique was better than the 2
nd
 technique that it reduced the volumes 
received doses (up to 400 cGy) and (>400-900 cGy) by 24% and 3.5% respectively. Also Dmean was 229 cGy for the 3
rd
 




 techniques respectively. These results indicated that the 3
rd
 
technique was favorable than the two other techniques, with respect to the right breast dose. 
By the analysis of Lung for all techniques, shown in figure (4-c), increases of lung doses were observed for the 3
rd
 
technique that V50% reached 9.9%. Also increasing of “Dmean = 161 cGy” was observed with the 3
rd
 technique while it was 




 techniques respectively. 
Figure 1. The isodose distributions for patient 1. (a) Two opposite tangential photon beams, (b) Two oblique 
photon beams and (c) Single electron beam. 
Figure 2. The comparisons between DVHs of patient 1 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) right lung and (d) Heart. 
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The analysis of heart DVHs for all techniques are shown in figure (4-d), no significant differences between the three 














3.3 Patient 3 
the isodose distributions using the three techniques are shown in “figure 5”.  It’s clear that the boost PTV coverage for 
each technique was accepted. The DVHs of boost PTV, ipsilateral breast, right lung and heart using the three techniques 
are shown in “figure 6”. 
From the boost PTV DVHs for all treatment plans shown in figure (6-a), we see similar boost PTV dose coverage. 
D95% was greater than 950 cGy and V95% was greater than 95% for all techniques. Also D100% was greater than 90% of the 
therapeutic dose for all techniques. 
From the right breast DVHs shown in figure (6-b), it was clear that the 3
rd
 technique presented the lowest right breast 
dose. The volumes received doses (up to 900 cGy) were decreased by about 22% when the 3
rd
 technique used compared 
to the 1
st
 technique. Also the volumes received doses (up to 400 cGy) and (>400-900 cGy) were decreased by 27% and 
10% respectively when the 3
rd
 technique used compared to the 2
nd
 technique.  The mean dose was 194 cGy for the 3
rd
 
technique, while it was 337cGy for the 2
nd
 technique and was 417 cGy for the 1
st
 technique. 
By the analysis of Lung and heart DVHs for all techniques, shown in figures (6-c) and (4.26-d) respectively, we didn’t 
find significant differences between the three techniques. Slight increases of lung doses were observed for the 2
nd
 













Figure 3. The isodose distributions for patient 2. (a) Two opposite tangential photon beams, (b) Two oblique 
photon beams and (c) Single electron beam. 
Figure 4. The comparisons between DVHs of patient 1 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
Figure 5. The isodose distributions for patient 3. (a) Two opposite tangential photon beams, (b) Two oblique 
photon beams and (c) Single electron beam. 
Figure 6 . The comparisons between DVHs of patient 13 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
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3.4 Patient 4 
The isodose distributions using the three techniques are shown in “figure 7”.  It’s clear that the boost PTV coverage 
for each technique was accepted. The DVHs of boost PTV, ipsilateral breast, right lung and heart using the three 
techniques are shown in “figure 8”.  
From the boost PTV DVHs for all treatment plans shown in figure (8-a), D100 of the boost PTV was greater than 900 
cGy (90%of therapeutic dose). D95% was greater than 950 cGy and V95% was greater than 95% for all techniques. 
From the right breast DVHs shown in figure (8-b), a significant decrease of breast dose was observed with the 3
rd
 
technique. The volumes received doses (up to 900 cGy) were decreased by about 22.5% when the 3
rd
 technique was 
used in comparison with the 1
st
 technique. Also the volumes received doses (up to 400 cGy) were decreased by 30% 
when the 3
rd
 technique was used in comparison with the 2
nd
 technique. And the volumes received doses (greater than 300 
cGy) were decreased by 18% when the 2
nd
 technique was used in comparison with the 1
st
 technique. 
By the analysis of Lung and heart DVHs for all techniques, shown in figures (8-c) and (8-d) respectively. (V50%) didn’t 














The isodose distributions using the three techniques are shown in “figure 9”.  It’s clear that the boost PTV coverage 
for each technique was accepted. The DVHs of boost PTV, ipsilateral breast, right lung and heart using the three 
techniques are shown in “figure 10”. 
From the boost PTV DVHs of all treatment plans, we see similar boost PTV dose coverage, as shown in figure (10-a). 
D95% was greater than 95%of therapeutic dose and V95% was greater than 95% for all techniques. A slight decrease of 
D100% = 832 cGy was observed with the 2
nd
 technique. The 2
nd
 technique presented the lowest HI = 6.1% while it was 




 techniques respectively. 
From the right breast DVHs shown in figure (10-b). The volumes received doses (up to 900 cGy) were decreased by 
about 7% when the 3
rd
 technique was used in comparison with the 1
st
 technique. Also the volumes received doses 
(>400cGy) were decreased by about 16% when the 2
nd
 technique was used in comparison with the 1
st
 technique.  
By the analysis of Lung for all techniques, shown in figure (10-c), a significant increases of lung doses were observed 
for the 3
rd
 technique that V50% reached 26.5% and Dmean =301cGy. 










Figure 7. The isodose distributions for patient 4. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
Figure 8. The comparisons between DVHs of patient 4 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
Figure 9.  The isodose distributions for patient 5. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
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3.6 Patient 6  
The isodose distributions using the three techniques are shown in “figure 11”. The DVHs of boost PTV, ipsilateral 
breast, right lung and heart using the three techniques are shown in “figure 12”. 
From the boost PTV DVHs of all treatment plans shown in figure (12-a). D100% of the boost PTV was greater than 900 








From the right breast DVHs shown in figure (12-b). The volumes received doses (up to 900 cGy) were decreased by 
about 20% when the 3
rd
 technique was used in comparison with the 1
st
 technique. The 3
rd
 technique was better than the 
2
nd
 technique that it reduced the volumes received doses (up to 400 cGy) and (>400-900 cGy) by 24.5% and 4% 
respectively. Dmean was 212 cGy for the 3
rd
 technique while it was 297 cGy and 395 cGy for the 2
nd




By the analysis of Lung DVH for all techniques shown in figure (12-c), Significant increases of lung doses were 
observed for the 3
rd
 technique that V50 reached 13%. Dmean was 169 cGy for the 3
rd
 technique while it was 58 cGy and 44 
cGy for the 2
nd
 and the 1
st
 techniques respectively. 
The analysis of heart DVHs for all techniques are shown in figure (12-d), slight increases were observed for the 3
rd
 
technique. Dmean was 71.5 cGy for the 3
rd
 technique while it was 12.8 cGy and 6.8 cGy for the 2
nd


















3.7 Patient 7  
the isodose distributions using the three techniques are shown in “figure 13”.  It’s clear that the boost PTV coverage 
for each technique was accepted. The DVHs of boost PTV, ipsilateral breast, right lung and heart using the three 
techniques are shown in “figure 14”. 
From the boost PTV DVHs of all treatment plans, we see similar boost PTV dose coverage, as shown in figure (14-a). 
D100% of the boost PTV was greater than 900 cGy (90%of therapeutic dose), D95% was greater than 950 cGy and V95% was 
greater than 95% for all techniques.  HI was 10.5% for the 3
rd






Figure 10. The comparisons between DVHs of patient 5 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
Figure 11. The isodose distributions for patient 6. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
Figure 12. The comparisons between DVHs of patient 6 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
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By the analysis of boost PTV, right breast, right lung DVH and heart DVHs for all techniques, shown in figures (14-b), 
(14-c) and (14-d) respectively, we didn’t find any effective differences between the three techniques. (V50%) for heart and 














3.8  Patient 8 
The isodose distributions using the three techniques are shown in “figure 15”. The DVHs of boost PTV, ipsilateral 
breast, right lung and heart using the three techniques are shown in “figure 16”. 
From the boost PTV DVHs of all treatment plans shown in figure (16-a), D100% of the boost PTV was greater than 900 





techniques while they were 829 cGy, 930 cGy and 91% for the 3
rd
 technique. Increasing of HI=21% was observed with the 
3
rd




 techniques respectively. 
From the right breast DVHs shown in figure (16-b). The volumes received doses (up to 900 cGy) were decreased by 
about 17.5% when the 3
rd
 technique was used in comparison with the 1
st
 technique. The volumes received doses (up to 
400 cGy) were decreased by about 22% when the 3
rd
 technique was used in comparison with the 2
nd
 technique. And the 
volumes received doses (greater than 300 cGy) were decreased by 13% when the 2
nd




By the analysis right lung and heart DVHs for all techniques, shown in figures (16-c) and (16-d) respectively, we didn’t 
find any significant differences between the three techniques. (V50%) didn’t exceed 5% of total volume for all techniques. A 

















Figure 13. The isodose distributions for patient 7. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
Figure 14. The comparisons between DVHs of patient 7 using two opposite tangential photon beams, two oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
Figure 15. The isodose distributions for patient 8. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
Figure 16. The comparisons between DVHs of patient 8 using two opposite tangential photon beams, two  oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
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3.9 Patient 9 
The isodose distributions using the three techniques are shown in “figure 17”. The DVHs of boost PTV, ipsilateral 
breast, right lung and heart using the three techniques are shown in “figure 18”. 
From the boost PTV DVHs of all treatment plans, we see similar boost PTV dose coverage for the 1
st
 and the 2
nd
 
techniques and Decrease of D100% = 876 cGy was observed for the 3
rd
 technique, as shown in figure (18-a). 
Increasing of HI= 32.6% was observed with the 3
rd
 technique while it was 5.9% and 6.5% for the 1
st
 and the 2
nd
 
techniques. Also increasing of the global maximum value was observed with the 3
rd
 technique “GM=1449 cGy”. 
From the right breast DVHs shown in figure (18-b), there were no effective differences between the 1
st
 and the 2
nd
 
techniques. For the 3
rd
 technique we observed that the maximum dose received by right breast increased to about 144% 
of therapeutic dose. 
By the analysis right lung and heart DVHs for all techniques, shown in figures (18-c) and (18-d) respectively, we didn’t 
find any significant differences between the three techniques. (V50%) didn’t exceed 5% of total volume for all techniques. 
But it was clear that the lowest heart and right lung dose was obtained with the 1
st
 technique. An increase of heart dose 
was observer with the 2
nd
 technique. 
It is clear that the 3
rd















3.10  Patient 10 
 the isodose distributions using the three techniques are shown in “figure 19”.  The DVHs of boost PTV, ipsilateral 
breast, right lung and heart using the three techniques are shown in “figure 20”. 
Increasing of HI= 83.4% was observed with the 3
rd
 technique while it was 4.7% and 2.8% for the 1
st
 and the 2
nd
 
techniques. Also increasing of the global maximum value was observed with the 3
rd
 technique “GM=1420 cGy” 
From the boost PTV DVHs of all treatment plans, we see similar boost PTV dose coverage for the 1
st
 and the 2
nd
 
techniques and poor coverage for the 3
rd
 technique, as shown in figure (20-a). Decreases of D100% = 324 cGy, D95% =520 
cGy and V95% = 58% were observed for the 3
rd
 technique.  
From the right breast DVHs shown in figure (20-b), there were no effective differences between the 1
st
 and the 2
nd
 
techniques. For the 3
rd
 technique we observed that the maximum dose received by right breast increased to about 142% 
of therapeutic dose. 
By the analysis right lung and heart DVHs for all techniques, shown in figures (20-c) and (20-d) respectively, we didn’t 
find any significant differences between the three techniques. (V50%) didn’t exceed 5% of total volume for all techniques.  
It is clear that the 3
rd
 technique wasn’t preferable for this case. 
 
 
Figure 17. The isodose distributions for patient 9. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
Figure 18. The comparisons between DVHs of patient 9 using two opposite tangential photon beams, two  oblique 
photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
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This work aimed to compare between three different techniques by which a prescribed dose delivered to the right 
breast boost PTV. Our goal was to determine the best technique in terms of dose delivery to the boost PTV while 
maintaining acceptable dose distributions in normal breast tissues and the OARs.  
Ten early-stage right breast cancer patients with different tumor sizes and locations were selected and the data was 
collected and analyzed.  
By the comparison of DVHs of boost PTV, ipsilateral breast and OARs for each patient using the three different 
techniques we concluded that: 
1- The 3
rd
 technique presented the lowest dose delivered to the normal breast tissues, however it delivered a high doses 
to the heart and the right lung in some cases. 
2- The 1
st
 technique presented the lowest dose delivered to the heart and the right lung, however it delivered a high 
doses to the normal breast tissues, and so it could be the technique of choice for young patient or patient with medical 
back ground showing disorders in heart or right lung.  
3- When the lung was closed to the tumor bed, the 3
rd
 technique presented the largest dose deliver to the lung and the 
volume receiving 500 cGy might reached 5%. 
4- For small size breast (that meaning the distance between the lung and the skin is small), the 3
rd
 technique presented 
the largest dose deliver to the lung and the volume receiving 500 cGy might reached 5%. 
5- As the thickness of breast decrease in the upper part , the lung becomes closer to the skin.so if the target located 
upper the 3
rd
 technique may deliver a high dose to the lung (except for large size breast). 
6- For superficial tumor bed, the 3
rd
 technique presented the accepted boost PTV dose coverage. So it considered as the 
best technique in delivering boost dose to tumor bed for cancer patient with superficial target. 
7- For large and/or deep tumor bed, the 1
st
 technique provided the beast boost PTV coverage with minimal dose 
delivered to OARs. So it considered as the technique of choice in delivering boost dose to tumor bed for cancer patient 
with large deep tumor bed. The 3
rd
 technique was unfavorable for this case because of its poor dose coverage to boost 
PTV. 
8- For inner boost PTV located close to the heart, the 2
nd
 technique was unfavorable because it delivered a high dose to 
the heart, while the 1
st
 technique presented the largest lung dose. 
Finally, we did not find a definite irradiation technique that could sufficiently deliver the boost dose to the boost PTV 
and totally spare the OARs, as the treatment planning is multifactorial process affected by multiple factors including 
radiation type and energy, technique of irradiation, target size, target location, target depth, breast size, distance between 
target and OARs, distance between the skin and OARs. 
So we recommended that there was no standard procedures could be considered as the  best technique to deliver the 
boost dose to tumor bed while maintaining acceptable dose distributions in normal breast tissues and the OARs, and an 
individualized treatment, several plans using different irradiation techniques should be developed for each patient 
individually to reach the best boost PTV dose coverage and with minimal OARs’ dose.  
Figure 19. The isodose distributions for patient 10. (a) Two opposite tangential photon beams, (b) Two 
oblique photon beams and (c) Single electron beam. 
Figure 20. The comparisons between DVHs of patient 20 using two opposite tangential photon beams, two  
oblique photon beams and single electron beam for (a) Boost PTV, (b) Right breast, (c) Right lung and (d) Heart. 
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